NCT05087680

Brief Summary

Investigators will use a generalized framework for the adaptation of EBIs to inform the development of a brief Acceptance and Commitment Therapy (ACT)-based culturally appropriate pre-exposure prophylaxis (PrEP) intervention tailored to young Black men who have sex with men (YBMSM), named ACTPrEP.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 13, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 21, 2021

Completed
1.9 years until next milestone

Study Start

First participant enrolled

September 14, 2023

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

November 19, 2024

Status Verified

November 1, 2024

Enrollment Period

2.2 years

First QC Date

September 13, 2021

Last Update Submit

November 17, 2024

Conditions

Keywords

ACTPrEP

Outcome Measures

Primary Outcomes (2)

  • ACTPrEP Feasibility

    ACTPrEP feasibility is measured by percentage of participants retained in the study.

    12 week visit

  • ACTPrEP Acceptability

    Acceptability is measured with the Client Satisfaction Questionnaire.

    12 week visit

Study Arms (2)

Control Group

ACTIVE COMPARATOR

Control group will include one 30-minute PrEP education session.

Behavioral: Enhanced Standard of Care

ACTPrEP

EXPERIMENTAL

ACTPrEP will include a 60-minute initial session and 30-minute sessions at 2, 6, and 12 weeks.

Behavioral: ACTPrEP

Interventions

ACTPrEPBEHAVIORAL

ACTPrEP will include a 60-minute initial session and a series of 30-minute follow-up sessions. Sessions will focus on the Thoughts, Emotions, Associations, Memories, and Sensations (TEAMS) relevant to PrEP uptake and adherence.

ACTPrEP

Enhanced Standard of Care (ESOC) will include one 30-minute PrEP education session.

Control Group

Eligibility Criteria

Age18 Years - 34 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • English speaking
  • Between 18-34 years old
  • Male sex assigned at birth
  • Identify as African American/Black
  • Not enrolled in another PrEP related study
  • Able to give consent
  • Not taken PrEP in past 3 months
  • Report having sex with a man in the past 3 months
  • PrEP-eligible according to CDC guidelines

You may not qualify if:

  • Participating in another PrEP study
  • Unable to provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Univeristy of Mississippi Medical Center

Jackson, Mississippi, 39216, United States

RECRUITING

Related Publications (1)

  • Arnold T, Giorlando KK, Barnett AP, Gaudiano BA, Antonaccio CM, Elwy AR, Patrick Edet P, Ward LM, Whiteley L, Bailey S, Rogers BG, Leigland A, Rusley JC, Brown LK. Acceptance-Based Pre-Exposure Prophylaxis Intervention (ACTPrEP) to Engage Young Black Men Who Have Sex With Men in the Southern United States: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2025 Jun 20;14:e65921. doi: 10.2196/65921.

Study Officials

  • Trisha Arnold, PhD

    Rhode Island Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Trisha Arnold, PhD

CONTACT

Larry Brown, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 13, 2021

First Posted

October 21, 2021

Study Start

September 14, 2023

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

November 19, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations